Rchr
J-GLOBAL ID：201501016188921159
Update date: Sep. 21, 2024
Hanamura Ichiro
ハナムラ イチロウ | Hanamura Ichiro
Affiliation and department：
Job title：
教授
Homepage URL (1)：
http://www.aichi-med-u.ac.jp/hospital/sh04/sh0401/sh040107/index.html
Research field (4)：
Tumor biology
, Internal medicine - General
, Genomics
, Hematology and oncology
Research keywords (14)：
Chromosomal translocation
, Genome editting
, KRAS
, FLT3
, MAFB
, MAF
, ARK5
, MN1
, TEL
, がん微小免疫環境
, ミトコンドリア
, myeloma
, lymphoma
, leukemia
Research theme for competitive and other funds (8)：
- 2024 - 2027 Generation and Application of High-Activity NK Cells with Genetic Modification in the NKG2D 3-prime-UTR miR-1245 Binding Region
- 2022 - 2025 ゲノム編集を利用したKRAS変異骨髄腫に対する新規治療標的薬の探索
- 2021 - 2024 Establishment of the platform for a drug discovery of multiple myeloma by targeting PBK-related signaling pathway
- 2021 - 2024 ADAMTS13 gene polymorphism genome editing creation of vascular endothelial cells and exploration for new leukemia therapies
- 2019 - 2022 Development of the novel target therapy for leukemia with FLT3 mutations, using genetically modified FLT3-mutation knock-in human myeloid leukemia cells
- 2018 - 2021 Basic research for development of novel cancer immunotherapy based on improvement of the cancer immunosuppressive microenvironment
- 2018 - 2021 Investigation of molecular mechanism by which PBK contributes to tumorigenesis in myeloma cells
- 2007 - 2008 Analysis of clinical feature and molecular pathogenesis of multiple myeloma with the gain of chromosome arm 1q21
Show all
Papers (79)：
-
Hideshige Seki, Shohei Mizuno, Sakura Saigusa, Yukie Sugita, Yusuke Iida, Saki Shinohara, Kaori Uchino, Tomohiro Horio, Ichiro Hanamura, Akiyoshi Takami. Primary Bladder Lymphoma with Extravesical Extension: A Case Report and Literature Review on Prognosis and Clinical Characteristics. Journal of clinical medicine. 2024. 13. 15
-
Yoshinori Kikuchi, Hideaki Shimada, Fumiyuki Yamasaki, Taku Yamashita, Koji Araki, Kohei Horimoto, Satoshi Yajima, Masakazu Yashiro, Keigo Yokoi, Haruhiko Cho, et al. Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2. International journal of clinical oncology. 2024. 29. 5. 512-534
-
Sivasundaram Karnan, Ichiro Hanamura, Akinobu Ota, Lam Quang Vu, Kaori Uchino, Tomohiro Horio, Satsuki Murakami, Shohei Mizuno, Md Lutfur Rahman, Md Wahiduzzaman, et al. ARK5 enhances cell survival associated with mitochondrial morphological dynamics from fusion to fission in human multiple myeloma cells. Cell death discovery. 2024. 10. 1. 56-56
-
Hiroaki Kitamura, Yasushi Kubota, Ichiro Hanamura, Sivasundaram Karnan, Rika Tomimasu, Michiaki Akashi, Shiho Tsuruda, Akiyoshi Takami, Shinya Kimura, Masaharu Miyahara. Chromosomal Translocations t(1; 22)(q21; q11.2) and t(6; 18)(p25; q21) in a Patient with Diffuse Large B-cell Lymphoma: FISH Analysis. 2023
-
加藤 康孝, 鈴木 進, 大久保 井久子, 山中 俊平, 犬飼 大輔, 中村 宏舞, 小川 徹也, 村上 五月, 花村 一朗, 高見 昭良, et al. 抗癌剤療法を受けている肺癌患者に対する3回目のSARS-CoV-2ワクチン接種の効果(The effect of third SARS-CoV-2 vaccination on lung cancer patients receiving anticancer drug therapy). 日本癌学会総会記事. 2023. 82回. 1392-1392
ｍore...
MISC (221)：
-
SAKAGUCHI Momona, 木村優花, 川村千菜実, 佐伯ななみ, IFTEKHAR Chowdhury Sajid, SIVASUNDARAM Karnan, 細川好孝, 花村一朗, 太田明伸, 太田明伸. Differential effect of free fatty acids on the survival of multiple myeloma cells. International Journal of Myeloma (Web). 2024. 14. 3
-
太田明伸, 太田明伸, 花村一朗, シバスンダラン カルナン, シバスンダラン カルナン, 武井則雄, IFTEKHAR Chowdhury Sajid, 兵頭寿典, 小西裕之, 都築忍, et al. A novel FIRRM-FIGNL1 interaction enhances the viability of multiple myeloma cells. International Journal of Myeloma (Web). 2024. 14. 3
-
高見昭良, 水野昌平, 榎本めぐみ, 堀尾知弘, 内野かおり, 高杉壮一, 松村沙織, 篠原早紀, 村上五月, 鈴木文乃, et al. ITP患者の長期予後. 日本血栓止血学会誌. 2024. 35. 2
-
加藤 康孝, 鈴木 進, 大久保 井久子, 山中 俊平, 犬飼 大輔, 中村 宏舞, 小川 徹也, 村上 五月, 花村 一朗, 高見 昭良, et al. 抗癌剤療法を受けている肺癌患者に対する3回目のSARS-CoV-2ワクチン接種の効果(The effect of third SARS-CoV-2 vaccination on lung cancer patients receiving anticancer drug therapy). 日本癌学会総会記事. 2023. 82回. 1392-1392
-
三枝 桜, 金杉 丈, 内野 かおり, 高杉 壮一, 鈴木 文乃, 堀尾 知弘, 村上 五月, 水野 昌平, 山本 英督, 花村 一朗, et al. VEXAS症候群の2例. 臨床血液. 2023. 64. 8. 820-820
ｍore...
Patents (1)：
Books (75)：
-
Characteristics of multiple myeloma by immunoglobulin isotypes
2024
-
骨髄腫ってどんな病気? 骨髄腫セミナー2019講演録 (リバイバル)
多発性骨髄腫情報誌 がんばりまっしょい 第19号、日本骨髄腫患者の会. P4-11 2023
-
特集 リンパ系腫瘍に対する新薬開発状況と今後の展望update 2023 「解説」多発性骨髄腫における1q異常とは
血液内科87(4) 科学評論社; 457-61 2023
-
多発性骨髄腫の高リスク染色体異常
日本臨牀81巻6号日本臨床社 794-799 2023
-
特集 多発性骨髄腫の病態解明と治療の進歩 発症と進展の分子機序
医学と薬学80巻6号自然科学社 2023
ｍore...
Education (2)：
- 1998 - 2002 Nagoya City University
- 1988 - 1994 Nagoya City University Medical Sciences
Professional career (1)：
- MD, PhD (Nagoya City University)
Work history (7)：
- 2015/04 - 現在 Aichi Medical University Division of Hematology Professor
- 2013/01 - 2015/03 Aichi Medical University Division of Hematology Associate professor
- 2011/04 - 2012/12 Aichi Medical University Division of Hematology Associate professor
- 2007/04 - 2011/03 Aichi Medical University Division of Hematology Associate professor
- 2006/04 - 2007/03 Aichi Medical University Division of Hematology Associate professor
- 2003/06 - 2006/03 University of Arkansas for Medical Sciences Myeloma Institute for Research and Therapy Posdoc
- 1994/04 - 2003/06 Nagoya City University
Show all
Association Membership(s) (9)：
日本骨髄腫学会
, THE JAPANESE SOCIETY OF HEMATOLOGY
, THE JAPANESE SOCIETY OF INTERNAL MEDICINE
, 日本リンパ網内系学会
, 日本輸血・細胞療法学会
, 日本造血・免疫細胞療法学会
, 日本血栓止血学会
, 日本血液疾患免疫療法学会
, 日本検査血液学会
